| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_25a6289b957369e15597b9b73392417e |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L24-10 |
| filingDate |
2019-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89985d4f8d51c69793e7e1735660f979
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07005e24cf34817993ca48f45f640f35
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0216f0a993147af4694a36f298b46ccd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8ebc82839a2fe242fdfe54726907499
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da0b346c065d4bccf1bb597904ae4ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7666026fb3849765af280d58a3e0684c |
| publicationDate |
2019-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
RU-2704256-C1 |
| titleOfInvention |
Method of preparation of autologous two-component fibrin adhesive |
| abstract |
FIELD: medicine.SUBSTANCE: invention refers to medicine, particularly to a method of preparing an autologous two-component fibrin adhesive. Method for preparation of autologous two-component fibrin adhesive including blood sampling into sterile test tubes with sodium citrate, centrifugation of blood plasma, then the produced thrombocyte enriched plasma containing fibrinogen, blood coagulation factors in physiological concentrations and live thrombocytes producing various growth factors are sampled and mixed with the second component containing calcium chloride solution and thrombin under certain conditions.EFFECT: method described above enables to obtain an autologous two-component fibrin glue which provides strong and fast adhesion.1 cl, 3 dwg |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2803272-C2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2758260-C1 |
| priorityDate |
2019-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |